# ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy

> **NCT00816049** · PHASE3 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 775 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia

## Interventions

- **DRUG:** 6MPindividualized
- **DRUG:** 6MPfixed

## Key facts

- **NCT ID:** NCT00816049
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2016-03-02
- **Final completion:** 2016-03-02
- **Target enrollment:** 775 (ACTUAL)
- **Last updated:** 2017-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00816049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00816049, "ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00816049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*